4Front Ventures Corp.
General ticker "FFNTF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $6.7M (TTM average)
4Front Ventures Corp. does not follow the US Stock Market performance with the rate: -19.1%.
Estimated limits based on current volatility of 62.4%: low 0.00$, high 0.00$
Factors to consider:
- Total employees count: 374 (-41.7%) as of 2023
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Regulatory and compliance, Commodity price volatility, Import laws/duties, Litigation risks, Liquidity and credit risks
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.05$, 0.16$]
- 2024-12-30 to 2025-12-30 estimated range: [0.05$, 0.15$]
Financial Metrics affecting the FFNTF estimates:
- Positive: with PPE of -0.7 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -2.79 <= 0.33
- Positive: Inventory ratio change, % of 0.34 <= 0.84
- Positive: -14.38 < Investing cash flow per share per price, % of -5.23
- Positive: Industry inventory ratio change (median), % of -0.40 <= -0.15
- Negative: negative Industry operating cash flow (median)
Short-term FFNTF quotes
Long-term FFNTF plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $104.57MM | $107.66MM | $97.44MM |
| Operating Expenses | $118.44MM | $122.68MM | $118.28MM |
| Operating Income | $-13.87MM | $-15.02MM | $-20.85MM |
| Non-Operating Income | $-10.48MM | $3.81MM | $-16.78MM |
| Interest Expense | $13.70MM | $12.61MM | $13.80MM |
| Income(Loss) | $-24.36MM | $-11.21MM | $-37.63MM |
| Taxes | $13.93MM | $10.08MM | $7.09MM |
| Other Income(Loss) | $0.00MM | $-25.59MM | $-46.91MM |
| Profit(Loss)* | $-38.31MM | $-46.90MM | $-91.65MM |
| Stockholders Equity | $37.53MM | $28.26MM | $-51.50MM |
| Assets | $255.54MM | $344.73MM | $263.95MM |
| Operating Cash Flow | $5.78MM | $8.77MM | $-1.84MM |
| Capital expenditure | $13.87MM | $2.43MM | $3.36MM |
| Investing Cash Flow | $-13.01MM | $-26.87MM | $-3.44MM |
| Financing Cash Flow | $10.89MM | $10.71MM | $-5.55MM |
| Earnings Per Share** | $-0.06 | $-0.07 | $-0.14 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.